undamentalytics Newsletter

DaVita balance sheet

At the end of fiscal 2025, DaVita had total assets of $17.48bn, total liabilities of $16.32bn and shareholders' equity of −$651m. It held $676m in cash against $10.34bn of debt: net debt of $9.67bn.

Balance sheet

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

DaVita: balance sheet, annual
Fiscal year2016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Cash and equivalents0.70.50.31.10.30.50.20.40.80.70.5
Receivables1.51.71.91.81.82.02.12.02.12.42.5
Inventory0.20.20.10.10.10.10.10.10.10.20.2
Total current assets4.08.88.43.73.13.23.23.13.74.14.1
Goodwill6.06.66.86.86.97.07.17.17.47.57.5
Total assets18.819.019.117.317.017.116.916.917.317.517.8
Accounts payable0.50.50.50.40.40.40.50.50.50.70.7
Total current liabilities2.73.14.92.42.52.42.62.63.03.12.9
Long-term debt8.99.28.28.07.98.78.78.39.210.210.7
Total debt9.29.410.28.28.29.09.08.49.510.310.8
Total liabilities12.913.114.113.814.114.814.714.215.216.316.7
Shareholders' equity4.64.73.72.11.40.80.71.10.1−0.7−0.6
Non-controlling interests and other (assets − liabilities − equity)1.21.21.31.41.51.61.51.72.01.81.7
Net debt (negative = net cash)8.58.99.87.17.88.58.78.18.79.710.3
Shares outstanding195m182m166m126m110m97m90m89m81m69m63m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: DVA vs LHBTSG vs DVADGX vs DVA

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from DaVita's SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to DaVita.